Method for determining early HCV seroconversion

US7122302B2 · kind B2 · utility

Assignee

• Roche Diagnostics GMBH · DE

Inventors

• Christoph Seidel · Weilheim, DE
• Ursula-Henrike Wienhues · Krailling, DE
• Urban Schmitt · Oberhausen, DE
• Manfred Motz · Hersbruck, DE
• Michael Wiedmann · Penzberg, DE
• Barbara Upmeier · Iffeldorf, DE
• Erwin Soutschek · Starnberg, DE

Key dates

• Filing date: Jun 29, 2001
• Grant date: Oct 17, 2006
• Expiry date: Jul 19, 2021

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y10S436/82
• WIPO field: Measurement
• WIPO sector: Instruments

Abstract

The present invention concerns a polypeptide which is composed of the amino acids 1207±10 to 1488±10 of a hepatitis C virus and of less than 20 foreign amino acids and the use of this polypeptide as an antigen in an immunological test.